THRX : Analysis & Opinions

  1. Elan Shareholders Bring Management To Heel

    June 17, 2013
    The rejection of Elan management's proposed transactions ought to accelerate the sale of the company.
  2. AstraZeneca Pays Up To Patch Up Another Key Area

    June 10, 2013
    In buying Pearl, AstraZeneca is taking some of the risk out of its valuable COPD franchise.
  3. Elan Continues To Make Baffling Strategic Decision

    May 21, 2013
    Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
  4. Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog

    December 21, 2012
    GlaxoSmithKline (GSK) and partner Amicus Therapeutics (FOLD) recently presented disappointing top-line six-month primary ...
  5. Glaxo's Anthrax Drug Gets FDA Nod - Analyst Blog

    December 18, 2012
    GlaxoSmithKline (GSK) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug ...
  6. Medivation and Other Big Movers In Healthcare on December 3, ...

    December 3, 2012
    After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. The healthcare ...
  7. Glaxo's Promacta Label Expanded - Analyst Blog

    November 20, 2012
    GlaxoSmithKline (GSK) recently announced that the US Food and Drug Administration (FDA) has approved an additional indication ...
  8. Healthcare Stocks, Including Covidien, Making Big Moves on November ...

    November 9, 2012
    The Nasdaq has risen 0.9%, the S&P 500 has moved up 0.5% and the Dow is trading up 0.2%, marking a bad morning for the market. ...
  9. Healthcare Stocks, Including BioMarin Pharmaceutical, Making ...

    November 5, 2012
    The Nasdaq has moved up 0.1%, the S&P 500 has declined 0.3% and the Dow has slipped 0.3% so far today. The healthcare sector ...
  10. Glaxo Misses on Both Counts - Analyst Blog

    November 1, 2012
    GlaxoSmithKline (GSK) reported third quarter 2012 earnings of 71 cents per American Depository Share (ADS), well below the ...
  11. Gilead and Other Big Movers In Healthcare on September 5, 2012

    September 5, 2012
    The market is on the rise this morning. The Nasdaq has increased 0.2%; the S&P 500 has risen 0.2%; and the Dow is trading ...
  12. Celgene and More Big Movers in Healthcare on August 31, 2012

    August 31, 2012
    The market is on the rise this morning. The Nasdaq has climbed 0.8%; the S&P 500 is up 0.8%; and the Dow has risen 0.9%. ...
  13. Healthcare Stocks, Including Warner, Making Big Moves on August ...

    August 29, 2012
    Currently, the Nasdaq has decreased 0.2%, the S&P 500 has been relatively flat and the Dow has remained steady. The healthcare ...
  14. Eli Lilly Among Healthcare's Biggest Movers on August 27, 2012

    August 27, 2012
    The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed 0.1%. ...
  15. Glaxo to Increase Stake in Amicus - Analyst Blog

    July 19, 2012
    Glaxo Group Limited, an affiliate of GlaxoSmithKline (GSK), and Amicus Therapeutics (FOLD) recently announced the expansion ...
  16. Healthcare Sector's Biggest Movers for July 17, 2012

    July 17, 2012
    The Nasdaq has slipped 0.1%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2% on a bad morning for the market. ...
  17. Biggest Healthcare Sector Movers for July 2, 2012

    July 2, 2012
    The market is currently down, with the Nasdaq falling 0.2%, the S&P 500 down 0.2% and the Dow decreasing 0.5%. The healthcare ...
  18. Hedge Fund Guru: Seth Klarman’s Baupost Top Holdings

    March 19, 2012
    Some value investors stay out of the spotlight. Seth Klarman is one of those under-the-radar names.
  19. Seth Klarman's Biggest Bets

    December 8, 2009
    It's always a good idea to watch the pros, especially guys like Seth Klarman.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center